Dihydroergotamine mesylate/ergotamine/sumatriptan abuse

Reactions Weekly ◽

10.2165/00128415-199807170-00021 ◽

1998 ◽

Vol &NA; (717) ◽

pp. 8

Author(s):

&NA;

Keyword(s):

Dihydroergotamine Mesylate

Download Full-text

Dihydroergotamine Mesylate Injection

10.31003/uspnf_m26090_03_01 ◽

2021 ◽

Keyword(s):

Dihydroergotamine Mesylate

Download Full-text

Dihydroergotamine mesylate

Reactions Weekly ◽

10.2165/00128415-199002830-00012 ◽

1990 ◽

Vol &NA; (283) ◽

pp. 4

Author(s):

&NA;

Keyword(s):

Dihydroergotamine Mesylate

Download Full-text

Dihydroergotamine Mesylate

Pediatric Injectable Drugs ◽

10.37573/9781585285402.083 ◽

2018 ◽

pp. 300-303

Keyword(s):

Dihydroergotamine Mesylate

Download Full-text

Office-Based Treatment of Acute Migraine With Dihydroergotamine Mesylate

Headache The Journal of Head and Face Pain ◽

10.1111/j.1526-4610.1993.hed3309471.x ◽

1993 ◽

Vol 33 (9) ◽

pp. 471-475 ◽

Author(s):

Paul Winner ◽

Donald Dalessio ◽

Ninan Mathew ◽

Carl Sadowsky ◽

L. Jay Turkewitz ◽

...

Keyword(s):

Acute Migraine ◽

Dihydroergotamine Mesylate

Download Full-text

MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2012.711319 ◽

2012 ◽

Vol 13 (13) ◽

pp. 1961-1968 ◽

Author(s):

Stephen Silberstein

Keyword(s):

Acute Treatment ◽

Dihydroergotamine Mesylate

Download Full-text

A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects

Headache The Journal of Head and Face Pain ◽

10.1111/head.13737 ◽

2020 ◽

Vol 60 (4) ◽

pp. 701-712 ◽

Author(s):

Detlef Albrecht ◽

Mic Iwashima ◽

Debbie Dillon ◽

Stuart Harris ◽

Jeff Levy

Keyword(s):

Healthy Adult ◽

Phase 1 ◽

Bioavailability Study ◽

Comparative Bioavailability ◽

Dihydroergotamine Mesylate ◽

Comparative Bioavailability Study

Download Full-text

Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog

British Journal of Pharmacology ◽

10.1038/bjp.2008.187 ◽

2008 ◽

Vol 154 (6) ◽

pp. 1254-1265 ◽

Author(s):

S B Shrewsbury ◽

M Stonerook ◽

J K Okikawa

Keyword(s):

Cardiovascular Effects ◽

Conscious Dog ◽

Dihydroergotamine Mesylate

Download Full-text

Dihydroergotamine Mesylate Relieves Pelvic Congestion

InPharma ◽

10.1007/bf03306498 ◽

1987 ◽

Vol 602 (1) ◽

pp. 7-7

Keyword(s):

Dihydroergotamine Mesylate ◽

Pelvic Congestion

Download Full-text

Clinical Experience With Patient Administered Subcutaneous Dihydroergotamine Mesylate in Refractory Headaches

Headache The Journal of Head and Face Pain ◽

10.1111/j.1526-4610.1992.hed3201021.x ◽

1992 ◽

Vol 32 (1) ◽

pp. 21-23 ◽

Author(s):

J. A. Klapper ◽

J. Stanton

Keyword(s):

Clinical Experience ◽

Dihydroergotamine Mesylate

Download Full-text

Comparing Dihydroergotamine Mesylate and Sumatriptan in the Management of Acute Migraine

PharmacoEconomics ◽

10.2165/00019053-199610010-00006 ◽

1996 ◽

Vol 10 (1) ◽

pp. 59-71 ◽

Author(s):

Katherine Payne ◽

Chris M. Kozma ◽

Bryan J. Lawrence

Keyword(s):

Acute Migraine ◽

Dihydroergotamine Mesylate

Download Full-text